| View |
|
DR-XY14601
|
Salbutamol (As Sulfate)
|
Resdil
|
2 mg/ 5 mL
|
Syrup
|
Anti-asthma (Bronchodilator)
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Reconstruction)
|
16 November 2023
|
06 March 2029
|
| View |
|
DR-XY14607
|
Alprazolam
|
Xanor
|
500 mcg
|
Tablet
|
Anxiolytic
|
Pfizer Pharmaceuticals LLC
|
Puerto Rico
|
Automatic Renewal
|
16 April 2020
|
21 March 2025
|
| View |
|
DR-XY14608
|
Betaxolol (As Hydrochloride)
|
Betoptic S
|
2.5 mg/mL (0.25%)
|
Sterile Ophthalmic Suspension
|
-
|
Alcon-Couvreur NV
|
Belgium
|
-
|
06 April 2021
|
18 April 2026
|
| View |
|
DR-XY14634-L
|
Dextrose
|
None
|
5% w/v
|
Solution For I.V. Infusion
|
-
|
Baxter Healthcare Phils., Inc.
|
Philippines
|
-
|
27 July 2021
|
27 April 2025
|
| View |
|
DR-XY14658
|
Lactated Ringer'S Solution
|
None
|
600mg NaCl, 312mg Na Lactate, 40mg KCl, 27mgCaCl3 Dihydrate
|
Solution For Iv Solution
|
-
|
B. Braun Melsungen AG
|
Germany
|
-
|
06 December 2019
|
13 March 2025
|
| View |
|
DR-XY14670
|
5% Dextrose in 0.9% Sodium Chloride
|
Unbranded
|
(See Reverse)
|
Solution For Intravenous Infusion
|
Parenteral
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
17 April 2024
|
19 April 2029
|
| View |
|
DR-XY14672
|
0.9% Sodium Chloride
|
Unbranded
|
(See Reverse)
|
Solution For Intravenous Infusion
|
Parenteral
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
21 April 2024
|
12 April 2029
|
| View |
|
DR-XY14700
|
Aluminum Hydroxide + Magnesium Hydroxide
|
None
|
225mg/200mg
|
Suspension
|
ANTACID
|
AM-Europharma
Corporation
|
Philippines
|
Automatic Renewal
|
23 February 2022
|
09 July 2027
|
| View |
|
DR-XY147010
|
Cotrimoxazole
|
Triphimox
|
960 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
27 August 2020
|
27 August 2025
|
| View |
DR-XY14715_PI_01.pdf
|
DR-XY14715
|
Fluorouracil
|
None
|
50 mg/mL (500mg/10mL)
|
Solution For Injection (I.V.)
|
Antineoplastic Agent
|
Hospira Australia Pty. Ltd.
|
Australia
|
Automatic Renewal
|
10 May 2023
|
31 July 2028
|
| View |
|
DR-XY14730
|
Mannitol
|
Unbranded
|
20%
|
Solution For Injection
|
Hyperosmotic Agent
|
Euro-med Laboratories Phil. Inc.
|
Philippines
|
Renewal
|
24 August 2023
|
27 January 2029
|
| View |
|
DR-XY14753
|
Cefazolin Sodium
|
Lupex
|
1g
|
Powder For Injection (Im/Iv)
|
-
|
yung shin pharmaceutial ind. Co., ltd.
|
Taiwan
|
-
|
26 December 2019
|
31 January 2025
|
| View |
|
DR-XY14798
|
Ketorolac Trometamol
|
Toradol
|
30 mg/mL
|
Solution For Injection (Im/Iv)
|
Non-Opioid Analgesic
|
Cenexi
|
France
|
Automatic Renewal
|
13 December 2022
|
23 May 2028
|
| View |
|
DR-XY14835
|
Atenolol
|
Therabloc
|
25 mg
|
Tablet
|
Beta-Adrenoceptor Blocker
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
04 March 2022
|
30 May 2027
|
| View |
|
DR-XY14851
|
Lisinopril
|
Zestril®
|
5 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
01 March 2024
|
24 June 2029
|
| View |
|
DR-XY14852
|
Lisinopril
|
Zestril®
|
20 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
12 February 2024
|
25 June 2029
|
| View |
|
DR-XY14853
|
Lisinopril (as dihydrate)
|
Zestril
|
10 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
20 February 2024
|
11 February 2029
|
| View |
|
DR-XY14863
|
Multivitamins + Iron + Calcium
|
Sangobion Forte
|
360mg/1.5mg/15mcg/200mg/400IU/75mg
|
Capsule
|
Vitamins + Hematinic + Mineral
|
PT. Merck, Tbk.
|
Indonesia
|
Renewal
|
18 February 2024
|
05 March 2029
|
| View |
|
DR-XY14880
|
Warfarin Sodium (As Clathrate)
|
Coumadin
|
1mg
|
Tablet
|
-
|
Taro Pharmaceutical Industries Ltd.
|
Israel
|
Automatic Renewal (Re-Issuance)
|
02 August 2022
|
23 August 2025
|
| View |
|
DR-XY14899
|
Aluminum Hychloride Hexahydrate
|
Driclor
|
185 mg/mL
|
Solution
|
-
|
Stiefel Laboratories (Ireland) Ltd.
|
Ireland
|
-
|
23 October 2020
|
03 October 2025
|